LABS.TO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 30, 2025

Report Source: 2025 1st Quarter Report

Analyst's Ratings for Medipharm Labs Corp (LABS.TO)

Based on 9 analysts giving stock ratings to Medipharm Labs Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
0
Buy
0
Hold
33
Sell
45
Strong Sell
22
Medipharm Labs Corp

Medipharm Labs Corp. Stock Analysis LABS.TO

Canada Health Care Nano Cap Report:
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 127 full-time employees. The company went IPO on 2018-02-09. The firm specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. The company develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. The firm cultivates and processes cannabis to sell as dried flower, pre-roll and other cannabis products for adult use, medical, and international markets. The firm also provides GMP flower sourcing, packaging, and distribution services for select international clients. Its wholly owned subsidiary Harvest Medicine Inc. operates medical clinics in Canada that provide medical cannabis patients with physician consultations for medical cannabis education and prescriptions. Its international subsidiaries include Beacon Medical Germany GmbH and Beacon Medical Australia Pty Ltd.
Read More

Medipharm Labs Corp (LABS.TO) Chart

Key Statistics of Medipharm Labs Corp (LABS.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.08CAD0.09

Today's Open

CAD0.09

Volume

211.02K

P/E Ratio (TTM)

-

52 Week Range

CAD0.06CAD0.10

Market Cap

36.11M

Avg. Volume

520.71K

Dividend Yield

-

Financial Metrics & Statements of Medipharm Labs Corp (LABS.TO)

FAQ's for Medipharm Labs Corp (LABS.TO)

  • According to Musaffa’s Shariah screening methodology, Medipharm Labs Corp (LABS.TO) is currently classified as NOT HALAL as of June 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.